[Systemic therapy of cerebral metastases in breast carcinoma].
Kreuser
E D
ED
Abteilung Innere Medizin mit Schwerpunkt Hämatologie und Onkologie, Universitätsklinikum Steglitz, Berlin.
Herrmann
R
R
Krauseneck
P
P
Mende
S
S
Thiel
E
E
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001812:Blood-Brain Barrier; D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary*; D001943:Breast Neoplasms; D002277:Carcinoma / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary; D003131:Combined Modality Therapy; D005260:Female; D012739:Gonadal Steroid Hormones / Q000627:therapeutic use; D006801:Humans; D008577:Meningeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary; D008593:Menopause; D011879:Radiotherapy Dosage
D000970:Antineoplastic Agents; D012739:Gonadal Steroid Hormones
Systemische Therapie zerebraler Metastasen beim Mammakarzinom.